Biotechnology Archives – RamaOnHealthcare

Pharma / Biotech: Biotechnology

Read recent healthcare news on biotechnology in healthcare. Stay current on trends with our daily newsletter. Also, research insights with our curated search portal.

MD Anderson VC arm joins $25M funding round for cancer drug company

2022-11-30T20:23:18-05:00

Becker's Healthcare November 30, 2022

MD Anderson VC arm joins $25M funding round for cancer drug company2022-11-30T20:23:18-05:00

What are Pfizer, Johnson & Johnson, and Sanofi doing in mental health?

2022-11-30T20:13:09-05:00

CB Insights November 30, 2022

What are Pfizer, Johnson & Johnson, and Sanofi doing in mental health?2022-11-30T20:13:09-05:00

Can AI Drive More Diversity in Drug Development?

2022-11-30T19:27:59-05:00

Medscape November 30, 2022

Can AI Drive More Diversity in Drug Development?2022-11-30T19:27:59-05:00

COVID-19 PREP Act Litigation: The Tip Of The Liability Iceberg

2022-11-30T17:50:01-05:00

Health Affairs November 30, 2022

COVID-19 PREP Act Litigation: The Tip Of The Liability Iceberg2022-11-30T17:50:01-05:00

IBM’s Quantum Computing Apps to Cure Disease, Nanofluidics Technology Controls Remote Drug Delivery in Space, More

2022-11-30T17:44:24-05:00

Bio-IT World November 30, 2022

IBM’s Quantum Computing Apps to Cure Disease, Nanofluidics Technology Controls Remote Drug Delivery in Space, More2022-11-30T17:44:24-05:00

AstraZeneca leads winners at Reuters Pharma Awards 2022

2022-11-30T17:36:09-05:00

pharmaphorum November 30, 2022

AstraZeneca leads winners at Reuters Pharma Awards 20222022-11-30T17:36:09-05:00

Three trends that will impact the life sciences industry in 2023

2022-11-30T17:35:16-05:00

pharmaphorum November 30, 2022

Three trends that will impact the life sciences industry in 20232022-11-30T17:35:16-05:00

Genomenon Inks AI/Genomics Deal with Three Rare Neuro-Disease Orgs

2022-11-30T17:12:05-05:00

Inside Precision Medicine November 30, 2022

Genomenon Inks AI/Genomics Deal with Three Rare Neuro-Disease Orgs2022-11-30T17:12:05-05:00

Large pharmas probe takeover of Horizon Therapeutics

2022-11-30T16:41:43-05:00

BioPharma Dive November 30, 2022

Large pharmas probe takeover of Horizon Therapeutics2022-11-30T16:41:43-05:00

Bluebird sells regulatory fast pass to Argenx for $102M

2022-11-30T16:39:45-05:00

BioPharma Dive November 30, 2022

Bluebird sells regulatory fast pass to Argenx for $102M2022-11-30T16:39:45-05:00

Gene editing startup iECURE returns to investors for fresh funding

2022-11-30T16:38:04-05:00

BioPharma Dive November 30, 2022

Gene editing startup iECURE returns to investors for fresh funding2022-11-30T16:38:04-05:00

The Most Expensive Health Care in the World Is Far From the Best

2022-11-30T16:33:10-05:00

Bloomberg November 30, 2022

The Most Expensive Health Care in the World Is Far From the Best2022-11-30T16:33:10-05:00

How AI-Based Drug Repurposing Could Help Prevent Repetitive Behavior Disorders

2022-11-30T14:56:47-05:00

HIT Consultant November 30, 2022

How AI-Based Drug Repurposing Could Help Prevent Repetitive Behavior Disorders2022-11-30T14:56:47-05:00

Rgenta Therapeutics Raises $52M for Integrative RNA-Targeting Discovery Platform

2022-11-30T14:54:16-05:00

HIT Consultant November 30, 2022

Rgenta Therapeutics Raises $52M for Integrative RNA-Targeting Discovery Platform2022-11-30T14:54:16-05:00

Nectin Therapeutics Raises $25M for Immuno-Oncology Therapies

2022-11-30T14:50:24-05:00

HIT Consultant November 30, 2022

Nectin Therapeutics Raises $25M for Immuno-Oncology Therapies2022-11-30T14:50:24-05:00

Eisai Alzheimer’s Drug Data Show Slowing of Decline But Safety Questions Linger

2022-11-30T14:28:17-05:00

MedCity News November 30, 2022

Eisai Alzheimer’s Drug Data Show Slowing of Decline But Safety Questions Linger2022-11-30T14:28:17-05:00

Is a new Alzheimer’s drug ‘the beginning of the end’ of the disease? What a new study reveals.

2022-11-30T13:13:07-05:00

Advisory Board November 30, 2022

Is a new Alzheimer’s drug ‘the beginning of the end’ of the disease? What a new study reveals.2022-11-30T13:13:07-05:00

After three years in prison, ‘CRISPR babies’ scientist is attempting a comeback

2022-11-29T19:45:25-05:00

STAT November 29, 2022

After three years in prison, ‘CRISPR babies’ scientist is attempting a comeback2022-11-29T19:45:25-05:00

States Where Biomedical Engineers Earn The Most Money In 2022

2022-11-29T19:38:00-05:00

Forbes November 29, 2022

States Where Biomedical Engineers Earn The Most Money In 20222022-11-29T19:38:00-05:00

Researchers use mRNA technology for potential universal flu vaccine

2022-11-29T19:13:45-05:00

Becker's Healthcare November 29, 2022

Researchers use mRNA technology for potential universal flu vaccine2022-11-29T19:13:45-05:00

Life sciences collaborations: Managing risk and resolving disputes throughout the life cycle

2022-11-30T17:37:46-05:00

Lexology November 29, 2022

Life sciences collaborations: Managing risk and resolving disputes throughout the life cycle2022-11-30T17:37:46-05:00

BigHat, cherry-picking opportunities amid stormy market, pens pact with Merck & Co.

2022-11-29T16:39:19-05:00

Fierce Biotech November 29, 2022

BigHat, cherry-picking opportunities amid stormy market, pens pact with Merck & Co.2022-11-29T16:39:19-05:00

Full-Life wants more, acquires New Jersey biotech in efforts to dominate radiopharmaceutical R&D

2022-11-29T16:36:34-05:00

Fierce Biotech November 29, 2022

Full-Life wants more, acquires New Jersey biotech in efforts to dominate radiopharmaceutical R&D2022-11-29T16:36:34-05:00

Biomolecular condensates: Tiny droplets with big potential

2022-11-29T16:25:30-05:00

BioPharma Dive November 29, 2022

Biomolecular condensates: Tiny droplets with big potential2022-11-29T16:25:30-05:00